AiBiologics
AiBiologics offers AI-driven tools to speed up antibody, diagnostic, and vaccine discovery. It combines a proprietary software and AI biologics discovery platform with a massively parallel protein screening capability to optimize discovery and design. The EpitopePredikt software identifies immunodominant sequences and the most likely antibody responses, supporting antibody discovery, diagnostic research, immunoassay development, and vaccine development. Its technology targets biotech and pharmaceutical companies seeking faster R&D outcomes in B2B collaborations.
AiBiologics
AiBiologics offers AI-driven tools to speed up antibody, diagnostic, and vaccine discovery. It combines a proprietary software and AI biologics discovery platform with a massively parallel protein screening capability to optimize discovery and design. The EpitopePredikt software identifies immunodominant sequences and the most likely antibody responses, supporting antibody discovery, diagnostic research, immunoassay development, and vaccine development. Its technology targets biotech and pharmaceutical companies seeking faster R&D outcomes in B2B collaborations.